Incidental Mutation 'R9132:Mapk1'
ID 693739
Institutional Source Beutler Lab
Gene Symbol Mapk1
Ensembl Gene ENSMUSG00000063358
Gene Name mitogen-activated protein kinase 1
Synonyms Erk2, 9030612K14Rik, Prkm1, p42mapk, MAPK2
MMRRC Submission 068929-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R9132 (G1)
Quality Score 225.009
Status Validated
Chromosome 16
Chromosomal Location 16801246-16865317 bp(+) (GRCm39)
Type of Mutation critical splice donor site (2 bp from exon)
DNA Base Change (assembly) T to C at 16856300 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000156154 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000069107] [ENSMUST00000115731] [ENSMUST00000232067] [ENSMUST00000232611] [ENSMUST00000232611]
AlphaFold P63085
Predicted Effect probably benign
Transcript: ENSMUST00000069107
SMART Domains Protein: ENSMUSP00000065983
Gene: ENSMUSG00000063358

DomainStartEndE-ValueType
S_TKc 23 311 1.06e-95 SMART
low complexity region 330 344 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000115731
SMART Domains Protein: ENSMUSP00000111396
Gene: ENSMUSG00000063358

DomainStartEndE-ValueType
S_TKc 23 311 1.06e-95 SMART
low complexity region 330 344 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000231821
Predicted Effect probably benign
Transcript: ENSMUST00000232067
Predicted Effect probably null
Transcript: ENSMUST00000232611
Predicted Effect probably null
Transcript: ENSMUST00000232611
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.6%
  • 20x: 98.6%
Validation Efficiency 97% (65/67)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
PHENOTYPE: Homozygous mutant embryos implant in the uterus, but die shortly thereafter failing to form extraembryonic tissues. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 65 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
AC133488.1 A T 16: 18,440,075 (GRCm39) V363E probably benign Het
Adamts16 A G 13: 70,901,408 (GRCm39) S890P probably benign Het
Amd1 A G 10: 40,169,158 (GRCm39) probably null Het
Apcs A G 1: 172,722,061 (GRCm39) I95T probably damaging Het
Arhgap18 A G 10: 26,730,886 (GRCm39) D188G probably benign Het
Arhgap42 C T 9: 9,011,419 (GRCm39) V456M probably damaging Het
Atp2a2 T C 5: 122,599,633 (GRCm39) Y586C probably damaging Het
Cbr1 G C 16: 93,406,794 (GRCm39) G170A probably benign Het
Cdh23 T A 10: 60,270,283 (GRCm39) probably benign Het
Cfap53 T A 18: 74,416,272 (GRCm39) Y2N probably damaging Het
Clcn3 A G 8: 61,382,136 (GRCm39) I511T probably damaging Het
Col28a1 T A 6: 8,014,993 (GRCm39) D804V probably damaging Het
Csmd2 A G 4: 128,443,007 (GRCm39) T3253A Het
Csta3 G A 16: 36,038,069 (GRCm39) V69I probably benign Het
Cyp2c40 A T 19: 39,762,317 (GRCm39) D443E probably damaging Het
Cyp7b1 A G 3: 18,151,476 (GRCm39) C246R probably benign Het
Dmxl1 C G 18: 50,072,639 (GRCm39) N2744K probably damaging Het
Dnai4 A G 4: 102,916,930 (GRCm39) M592T probably damaging Het
Dpyd T A 3: 118,710,897 (GRCm39) I435N probably damaging Het
Fat2 A T 11: 55,189,436 (GRCm39) L1194Q possibly damaging Het
Firrm A G 1: 163,814,514 (GRCm39) I143T probably damaging Het
Gabrg1 A T 5: 70,939,622 (GRCm39) I170N possibly damaging Het
Gon4l C T 3: 88,815,484 (GRCm39) P2016S probably benign Het
Hax1 T C 3: 89,903,127 (GRCm39) R251G probably damaging Het
Hbq1b A T 11: 32,237,228 (GRCm39) K41* probably null Het
Ido2 G A 8: 25,023,933 (GRCm39) P302S probably damaging Het
Igf2bp2 G A 16: 21,900,502 (GRCm39) T213I probably damaging Het
Itga2 A T 13: 115,014,298 (GRCm39) L210* probably null Het
Kdm1b G A 13: 47,225,458 (GRCm39) S547N probably benign Het
Ltbp2 G A 12: 84,837,864 (GRCm39) P1192L probably benign Het
Lyz2 A T 10: 117,116,562 (GRCm39) C95* probably null Het
Mafa A T 15: 75,619,048 (GRCm39) S242T possibly damaging Het
Mta1 T A 12: 113,100,025 (GRCm39) V645E probably damaging Het
Muc5ac T C 7: 141,363,529 (GRCm39) I2280T unknown Het
Naa35 T C 13: 59,772,341 (GRCm39) I438T possibly damaging Het
Necab2 T C 8: 120,189,303 (GRCm39) Y158H probably damaging Het
Nphp3 T A 9: 103,897,980 (GRCm39) L523Q probably damaging Het
Ogdh A T 11: 6,290,488 (GRCm39) I369F probably benign Het
Pglyrp4 C T 3: 90,635,238 (GRCm39) Q28* probably null Het
Pla2g4a C T 1: 149,747,230 (GRCm39) V319I probably benign Het
Plk3 ACACTCAC ACAC 4: 116,989,090 (GRCm39) probably benign Het
Prdm6 C A 18: 53,598,019 (GRCm39) A127D unknown Het
Prop1 T G 11: 50,843,037 (GRCm39) E50A Het
Ripk1 A G 13: 34,212,184 (GRCm39) N498S probably benign Het
Rnf213 A G 11: 119,374,742 (GRCm39) N5069S Het
Saa3 T C 7: 46,362,121 (GRCm39) D41G probably damaging Het
Setd2 T C 9: 110,374,385 (GRCm39) probably null Het
Shbg G A 11: 69,506,430 (GRCm39) L327F probably benign Het
Slc12a5 G A 2: 164,835,876 (GRCm39) probably benign Het
Slc1a4 C T 11: 20,258,527 (GRCm39) G304D probably damaging Het
Slf1 T C 13: 77,249,073 (GRCm39) K372E probably benign Het
Smad2 T A 18: 76,395,573 (GRCm39) I4N possibly damaging Het
Smad6 A C 9: 63,914,870 (GRCm39) S300A probably benign Het
Spata31h1 T C 10: 82,127,896 (GRCm39) T1705A possibly damaging Het
Spem2 T A 11: 69,707,414 (GRCm39) probably benign Het
Syde1 T C 10: 78,425,340 (GRCm39) S224G probably benign Het
Tacc1 A T 8: 25,672,151 (GRCm39) V359E possibly damaging Het
Tex15 T G 8: 34,067,554 (GRCm39) V2328G possibly damaging Het
Tmem43 A C 6: 91,459,291 (GRCm39) D254A probably benign Het
Trav6d-3 T A 14: 52,964,210 (GRCm39) Y58N possibly damaging Het
Trrap A G 5: 144,726,362 (GRCm39) E437G probably benign Het
Wars1 A G 12: 108,827,199 (GRCm39) F474L probably benign Het
Zfp169 T C 13: 48,644,557 (GRCm39) E190G unknown Het
Zfp541 T A 7: 15,816,966 (GRCm39) V918D probably benign Het
Zfp747 T C 7: 126,974,922 (GRCm39) D26G probably damaging Het
Other mutations in Mapk1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00944:Mapk1 APN 16 16,853,322 (GRCm39) missense probably benign 0.00
IGL01486:Mapk1 APN 16 16,836,144 (GRCm39) splice site probably benign
IGL01764:Mapk1 APN 16 16,801,597 (GRCm39) missense possibly damaging 0.50
IGL02138:Mapk1 APN 16 16,841,316 (GRCm39) missense probably benign 0.18
IGL02701:Mapk1 APN 16 16,833,770 (GRCm39) missense probably benign 0.00
R0517:Mapk1 UTSW 16 16,833,910 (GRCm39) missense probably benign 0.02
R1609:Mapk1 UTSW 16 16,856,170 (GRCm39) splice site probably benign
R1862:Mapk1 UTSW 16 16,844,293 (GRCm39) missense probably benign 0.36
R2885:Mapk1 UTSW 16 16,844,309 (GRCm39) missense probably benign
R4205:Mapk1 UTSW 16 16,856,321 (GRCm39) intron probably benign
R4959:Mapk1 UTSW 16 16,836,170 (GRCm39) missense probably damaging 1.00
R5694:Mapk1 UTSW 16 16,836,333 (GRCm39) missense probably benign 0.02
R6630:Mapk1 UTSW 16 16,844,249 (GRCm39) missense probably damaging 1.00
R6809:Mapk1 UTSW 16 16,853,326 (GRCm39) missense probably benign 0.09
R8230:Mapk1 UTSW 16 16,843,930 (GRCm39) missense noncoding transcript
R9214:Mapk1 UTSW 16 16,853,549 (GRCm39) missense probably benign 0.02
R9373:Mapk1 UTSW 16 16,836,154 (GRCm39) missense probably benign 0.17
Predicted Primers PCR Primer
(F):5'- ACTCCCTTGACCATGACAACTTG -3'
(R):5'- GACCGTCACAGTGTCTAAGG -3'

Sequencing Primer
(F):5'- TTGACCATGACAACTTGCGACTG -3'
(R):5'- TCACAGTGTCTAAGGGCTGC -3'
Posted On 2022-01-20